혈액종양내과 박세훈 교수

학력
2020.09	성균관대학교 의과대학 박사학위 취득
2016.02	서울대학교 의과대학 석사학위 취득
2009.02	서울대학교 의과대학 졸업

경력
2022.03 ~현재	삼성서울병원 혈액종양내과 조교수
2019.12 ~ 2022.02	삼성서울병원 혈액종양내과 임상조교수
2017.12 ~ 2019.11	삼성서울병원 혈액종양내과 임상강사
2016.06 ~ 2017.11	Roche/Genentech
2012.03 ~ 2016.02	서울대학교병원 내과 레지던트 수료
2011.03 ~ 2012.02	서울대학교병원 인턴 수료

학회활동
대한내과학회 회원
대한암학회 회원
대한폐암학회 회원
미국암연구학회(AACR) 회원
미국임상암학회(ASCO) 회원
세계폐암학회(IASLC) 회원

수상이력
2021.11	보건의료기술진흥 유공자 정부포상 장관표창

Mol Cancer Res / 2020.09.30 Clinical characteristics and exploratory genomic analyses of germline BRCA1 or BRCA2 mutations in breast cancer Sehhoon Park ¹, Eunjin Lee , Seri Park , Sohee Lee , Seok Jin Nam , Seok Won Kim , Jeong Eon Lee , Jong-Han Yu , Ji-Yeon Kim , Jin Seok Ahn , Young-Hyuck Im , Woong-Yang Park , Kyunghee Park , Yeon Hee Park

View PubMed

Expert Opin Pharmacother / 2020.11.30 Evaluating entrectinib as a treatment option for non-small cell lung cancer Jiyun Lee ¹, Sehhoon Park , Hyun Ae Jung , Jong-Mu Sun , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Myung-Ju Ahn

View PubMed

J Neurooncol / 2020.09.30 Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR Minjung Seong ¹, Sehhoon Park , Sung Tae Kim , Sung Goo Park , Yi Kyung Kim , Hyung-Jin Kim , Myung-Ju Ahn

View PubMed

Cancer Res Treat / 2020.10.31 EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation Sehhoon Park ¹, Bo Mi Ku , Hyun Ae Jung , Jong-Mu Sun , Jin Seok Ahn , Se-Hoon Lee , Keunchil Park , Myung-Ju Ahn

View PubMed

Cancer / 2020.09.01 Biomarker?driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum?based chemotherapy Sehhoon Park ¹, Joonho Shim , Peter G S Mortimer , Simon A Smith , Robert E Godin , Simon J Hollingsworth , Hee-Jung Kim , Hyun Ae Jung , Jong-Mu Sun , Woong-Yang Park , Jin Seok Ahn , Myung-Ju Ahn , Se-Hoon Lee , Keunchil Park

View PubMed

Ann Oncol / 2020.10.31 A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy S Park ¹, M-H Lee , M Seong , S T Kim , J-H Kang , B C Cho , K H Lee , E K Cho , J-M Sun , S-H Lee , J S Ahn , K Park , M-J Ahn

View PubMed

ANN ONCOL 2020 10.1016/j.annonc.2020.08.2234 Osimertinib in central nervous system progressive EGFR-mutant lung cancer do we need to detect T790M? Park¹, S; Ahn, MJ

View PubMed

J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status Lee¹, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

View PubMed

BIOLOGY-BASEL 2020 10.3390/biology9100326 Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations Are They Different from Those with Common EGFR Mutations? Jung¹, HA; Park, S; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Park, K

View PubMed

ANN ONCOL 2020 10.1016/j.annonc.2020.06.017 A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy Park¹, S; Lee, MH; Seong, M; Kim, ST; Kang, JH; Cho, BC; Lee, KH; Cho, EK; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

View PubMed

CANCER RES TREAT 2020 10.4143/crt.2020.278 EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation Park¹, S; Ku, BM; Jung, HA; Sun, JM; Ahn, JS; Lee, SH; Park, K; Ahn, MJ

View PubMed

J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity Hong¹, TH; Cha, H; Shim, JH; Lee, B; Chung, J; Lee, C; Kim, NKD; Choi, YL; Hwang, S; Lee, Y; Park, S; Jung, HA; Kim, JY; Park, YH; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH; Park, WY

View PubMed

J NEURO-ONCOL 2020 10.1007/s11060-020-03617-2 Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal added value of contrast-enhanced 2D axial T2 FLAIR Seong¹, M; Park, S; Kim, ST; Park, SG; Kim, YK; Kim, HJ; Ahn, MJ

View PubMed

MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108 Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer Park¹, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH

View PubMed

CANCER 2020 10.1002/cncr.33048 Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy Park¹, S; Shim, J; Mortimer, PGS; Smith, SA; Godin, RE; Hollingsworth, SJ; Kim, HJ; Jung, HA; Sun, JM; Park, WY; Ahn, JS; Ahn, MJ; Lee, SH; Park, K

View PubMed

EXPERT OPIN PHARMACO 2020 10.1080/14656566.2020.1798932 Evaluating entrectinib as a treatment option for non-small cell lung cancer Lee¹, JY; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

View PubMed

J Thorac Oncol / 2019.12.31 In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing. Sehhoon Park ¹, Se-Hoon Lee , Keunchil Park

View PubMed

AACR / 2019년 Clinical characteristics and combined somatic mutation using target sequencing among breast cancer patients with germline BRCA mutation Park Sehhoon¹, Lee Eunjin, Park Seri, Lee Sohee, Hur Joon Young, Yoon Sang Eun, Lee Kangkook, Cho Jang Ho, Kim Ji-Yeon, Ahn Jin Seok

J Thorac Oncol / 2019.09.30 DNA damage response and repair pathway alteration and its association with tumor mutation burden and platinum-based chemotherapy in SCLC Sehhoon Park ¹, Hayoon Lee , Boram Lee , Se-Hoon Lee , Jong-Mu Sun , Woong-Yang Park , Jin Seok Ahn , Myung-Ju Ahn , Keunchil Park

View PubMed

Lung Cancer / 2019.01.31 Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor Sehhoon Park ¹, Joungho Han , Jong-Mu Sun

View PubMed

Lung Cancer / 2018.10.31 Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial Sung Won Lim ¹, Sehhoon Park , Youjin Kim , Jang Ho Cho , Song Ee Park , Hansang Lee , Hee Kyung Kim , Sung Min Kim , Jong Mu Sun , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Myung-Ju Ahn

View PubMed

J Thorac Oncol /2018.06.05 Characteristics and outcome of ROS1-positive non?small cell lung cancer patients in routine clinical practice Sehhoon Park ¹, Beung-Chul Ahn , Sung Won Lim , Jong-Mu Sun , Hye Ryun Kim , Min Hee Hong , Se-Hoon Lee , Jin Seok Ahn , Keunchil Park , Yoon La Choi , Byoung Chul Cho , Myung-Ju Ahn

View PubMed

PLoS One / 2018.01.31 Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor Sehhoon Park ¹, Seunggyun Ha , Se-Hoon Lee , Jin Chul Paeng , Bhumsuk Keam , Tae Min Kim , Dong-Wan Kim , Dae Seog Heo

View PubMed

Korean J Intern Med / 2017.04.14 KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer Sehhoon Park ¹, Ji-Yeon Kim , Se-Hoon Lee , Beomseok Suh , Bhumsuk Keam , Tae Min Kim , Dong-Wan Kim , Dae Seog Heo

View PubMed

Ann Oncol / 2017.04.01 Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma J-K Lee ¹, S Louzada , Y An , S Y Kim , S Kim , J Youk , S Park , S H Koo , B Keam , Y K Jeon , J-L Ku , F Yang , T M Kim , Y S Ju

View PubMed

BMC Cancer / 2017.05.15 Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma Yeonghun Lee ¹, Sehhoon Park , Se-Hoon Lee , Hyunju Lee

View PubMed

Atherosclerosis / 2016.02.28 Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults Beomseok Suh ¹, Sehhoon Park , Dong Wook Shin , Hongkeun Ahn , Seongcheol Cho , Seung-Pyo Lee , Eun-Ah Park , Hyejin Lee , Jin Ho Park , BeLong Cho

View PubMed

Medicine (Baltimore) / 2016.01.31 Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome Sehhoon Park ¹, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, Jin-Soo Kim

View PubMed

Tuberc Respir Dis (Seoul) / 2015.06.30 A case of statin-induced interstitial pneumonitis due to rosuvastatin Se Yong Kim ¹, Se Jin Kim , Doran Yoon , Seung Wook Hong , Sehhoon Park , Chan-Young Ock

View PubMed

Hepatology / 2015.02.13 High liver fibrosis index FIB?4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers Beomseok Suh ¹, Sehhoon Park, Dong Wook Shin, Jae Moon Yun, Hyung-Kook Yang, Su Jong Yu, Cheong-Il Shin, Jin-Soo Kim, Eunmi Ahn, Hyejin Lee, Jin Ho Park, BeLong Cho

View PubMed

날짜		월 01	화 02	수 03	목 04	금 05	토 06	일 07	월 08	화 09	수 10	목 11	금 12	토 13	일 14	월 15	화 16	수 17	목 18	금 19	토 20	일 21	월 22	화 23	수 24	목 25	금 26	토 27	일 28	월 29	화 30	수 31
오전
오후

날짜					목 01	금 02	토 03	일 04	월 05	화 06	수 07	목 08	금 09	토 10	일 11	월 12	화 13	수 14	목 15	금 16	토 17	일 18	월 19	화 20	수 21	목 22	금 23	토 24	일 25	월 26	화 27	수 28	목 29	금 30
오전
오후

게재일	2014-10-22
발표년월	2012-05	구분	국내
학술지	가정의학회지
논문명(국문)
논문명(영문)
요약문	td	발행정보	2010;31(10):778-785
책임저자	이정권
저자	박주현, 이선진, 곽정임, 심재용, 이정권	제 1저자	박주현
초록첨부	test
논문첨부

혈액종양내과 박세훈 교수

학력

경력

학회활동

수상이력